Trials / Completed
CompletedNCT02413541
The Pilot Study of the Efficacy of Polymyxin-B Hemoperfusion in Critically Ill Patients With Severe Sepsis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This research project is a study to immunology changes in critically ill patients with severe sepsis by using Endotoxin Activity Assay (EAA) combined with Polymyxin-B Hemoperfusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Polymyxin-B Hemoperfusion | Endotoxin removal |
| PROCEDURE | Standard treatment |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- Completion
- 2017-08-30
- First posted
- 2015-04-10
- Last updated
- 2021-03-05
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02413541. Inclusion in this directory is not an endorsement.